Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Citation metadata

From: PLoS ONE(Vol. 12, Issue 2)
Publisher: Public Library of Science
Document Type: Brief article; Correction notice
Length: 157 words
Lexile Measure: 560L

Document controls

Main content

Source Citation

Source Citation   

Gale Document Number: GALE|A481039877